Intensity Therapeutics Inc.
Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
New patient enrollment activities resumed in a limited number of U.S. sites in the soft tissue sarcoma Phase 3 INVINCIBLE-3 Study in the third…